Filing 2023 Q3 compared to 2023 Q2 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Roderick Wong
Managing Partner
New York, New York
14 Nov 2023
Previously RTW Master Fund, Ltd., RTW Innovation Master Fund Ltd., and RTW Biotech Opportunities Ltd. made separate 13F Notice filings and were listed in the reporting person's Form 13F as Other Included Managers. The reporting person has determined to cease making such 13F Notice filings and will continue to report in its Form 13F filings the Section 13F securities held by RTW Master Fund, Ltd., RTW Innovation Master Fund Ltd., and RTW Biotech Opportunities Ltd.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.